Dr. Tachapol Virunhagarun is an accomplished hematologist at Samitivej Sukhumvit Hospital with advanced training in cancer immunotherapy, cell therapy, and epigenetic control of gene expression from leading global institutions, including MIT, University of Melbourne, and SITC (USA). A graduate of Mahidol University, he also holds the Thai Board of Hematology certification and completed a clinical observership at Oregon Health & Science University (OHSU). His expertise bridges clinical hematology and cutting-edge therapeutic innovations such as cell and gene therapy.

Educational Qualification:

• M.D. – Faculty of Medicine, Siriraj Hospital, Mahidol University (2015)
• Thai Board of Hematology – Faculty of Medicine, Siriraj Hospital, Mahidol University (2020)
• Clinical Observership in Hematology – Oregon Health & Science University (OHSU), USA (2020)
• Certificate of Achievement in Disease Screening in Public Health – University of Geneva & University of Lausanne (2021)
• Certificate of Professional Achievement in Making a Cell Therapy (Principles and Practice of Manufacturing) – Massachusetts Institute of Technology (MIT), USA (2023)
• Certificate of Achievement in Epigenetic Control of Gene Expression – University of Melbourne (2023)
• Certificate of Professional Achievement in Cancer Immunotherapy – Society for Immunotherapy of Cancer (SITC), Milwaukee (2024)

Professional Experience:

• Consultant Hematologist – Samitivej Sukhumvit Hospital
• Clinical Observer – Oregon Health & Science University, USA